GlaxoSmithKline and one of its key executives are facing possible manslaughter charges re. side-effects of an anti-Hepatitis "B" vaccine

US VACCINE MAKER TARGET OF HOMOCIDE INVESTIGATION
In a criminal case guaranteed to send shockwaves throughout the international pharmaceutical industry, French authorities are targeting a US-based drug company and its executives in a homicide investigation. The multi-billion dollar corporation GlaxoSmithKline and one of its key executives are facing possible manslaughter charges stemming from allegations that the company failed to fully disclose side effects from an anti-Hepatitis "B" vaccine distributed between 1994 and 1998. Also being investigated is the French-based drug company Sanofi Pasteur, which also sold doses of the Hepatitis "B" vaccine, according to French news sources
Read article at newswithviews.com